201 related articles for article (PubMed ID: 31954835)
1. Nanoparticles guided drug delivery and imaging in gastric cancer.
Nagaraju GP; Srivani G; Dariya B; Chalikonda G; Farran B; Behera SK; Alam A; Kamal MA
Semin Cancer Biol; 2021 Feb; 69():69-76. PubMed ID: 31954835
[TBL] [Abstract][Full Text] [Related]
2. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
3. Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: Studies in vitro and in vivo.
Wang YR; Yang SY; Chen GX; Wei P
Biochem Biophys Res Commun; 2018 Apr; 499(1):8-16. PubMed ID: 29534962
[TBL] [Abstract][Full Text] [Related]
4. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
5. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
6. Nanotherapeutics to overcome conventional cancer chemotherapy limitations.
Chidambaram M; Manavalan R; Kathiresan K
J Pharm Pharm Sci; 2011; 14(1):67-77. PubMed ID: 21501554
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic nanoparticles for drug delivery in cancer.
Cho K; Wang X; Nie S; Chen ZG; Shin DM
Clin Cancer Res; 2008 Mar; 14(5):1310-6. PubMed ID: 18316549
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer.
Cai J; Qian K; Zuo X; Yue W; Bian Y; Yang J; Wei J; Zhao W; Qian H; Liu B
J Biomater Appl; 2019 May; 33(10):1394-1406. PubMed ID: 30952195
[TBL] [Abstract][Full Text] [Related]
9. Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential.
Fernandes E; Ferreira D; Peixoto A; Freitas R; Relvas-Santos M; Palmeira C; Martins G; Barros A; Santos LL; Sarmento B; Ferreira JA
Int J Pharm; 2019 Oct; 570():118646. PubMed ID: 31465836
[TBL] [Abstract][Full Text] [Related]
10. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
11. The application of nanoparticles in diagnosis and theranostics of gastric cancer.
Li R; Liu B; Gao J
Cancer Lett; 2017 Feb; 386():123-130. PubMed ID: 27845158
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites.
Dong X; Chu D; Wang Z
Theranostics; 2017; 7(3):751-763. PubMed ID: 28255364
[TBL] [Abstract][Full Text] [Related]
13. Folic acid functionalized nanoparticles as pharmaceutical carriers in drug delivery systems.
Narmani A; Rezvani M; Farhood B; Darkhor P; Mohammadnejad J; Amini B; Refahi S; Abdi Goushbolagh N
Drug Dev Res; 2019 Jun; 80(4):404-424. PubMed ID: 31140629
[TBL] [Abstract][Full Text] [Related]
14. Molecular targeted treatment and drug delivery system for gastric cancer.
Jiang L; Gong X; Liao W; Lv N; Yan R
J Cancer Res Clin Oncol; 2021 Apr; 147(4):973-986. PubMed ID: 33550445
[TBL] [Abstract][Full Text] [Related]
15. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
16. Prussian blue nanoparticles: Synthesis, surface modification, and application in cancer treatment.
Gautam M; Poudel K; Yong CS; Kim JO
Int J Pharm; 2018 Oct; 549(1-2):31-49. PubMed ID: 30053487
[TBL] [Abstract][Full Text] [Related]
17. Glyco-nanoparticles: New drug delivery systems in cancer therapy.
Khan H; Mirzaei HR; Amiri A; Kupeli Akkol E; Ashhad Halimi SM; Mirzaei H
Semin Cancer Biol; 2021 Feb; 69():24-42. PubMed ID: 31870939
[TBL] [Abstract][Full Text] [Related]
18. Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.
Wang L; You X; Lou Q; He S; Zhang J; Dai C; Zhao M; Zhao M; Hu H; Wu J
Biomater Sci; 2019 Oct; 7(10):4218-4229. PubMed ID: 31389415
[TBL] [Abstract][Full Text] [Related]
19. Gambogic acid-loaded PEG-PCL nanoparticles act as an effective antitumor agent against gastric cancer.
Zhang D; Zou Z; Ren W; Qian H; Cheng Q; Ji L; Liu B; Liu Q
Pharm Dev Technol; 2018 Jan; 23(1):33-40. PubMed ID: 29069711
[TBL] [Abstract][Full Text] [Related]
20. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy.
Zhang E; Xing R; Liu S; Li K; Qin Y; Yu H; Li P
Int J Biol Macromol; 2019 Apr; 126():662-672. PubMed ID: 30599159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
